JF
ALLR

Jump Financial’s Allarity Therapeutics ALLR Stock Holding History

Jump Financial’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,293
Closed -$8.26K – 1607
2024
Q2 		$8.26K Buy
+1,293
New +$50.7K ﹤0.01% 1733

Other funds holding ALLR

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Jump Financial's ALLR Position: Q3 2024 in Review

Jump Financial sold out of Allarity Therapeutics (ALLR) in Q3 2024, closing a stake of 1,293 shares — an estimated $8.26K sold.

Jump Financial first reported a position in ALLR in Q2 2024 and held it in 1 quarter. The position peaked at $8.26K in Q2 2024. 4 funds tracked by Wall St. Rank hold ALLR as of Q3 2024.

  • Jump Financial reported no remaining Allarity Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 1,293 Allarity Therapeutics shares in Q3 2024, an estimated $8.26K.
  • Jump Financial first reported a position in Allarity Therapeutics in Q2 2024 and held it in 1 quarter.
  • Jump Financial's Allarity Therapeutics position peaked at $8.26K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.